These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19139202)

  • 21. Antifolate/antiproliferative therapy in rheumatoid arthritis.
    Cutolo M
    Clin Exp Rheumatol; 2005; 23(4):435-7. PubMed ID: 16095109
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biochemical markers of bone turnover. New aspect. Therapy of rheumatoid arthritis for bone metabolic marker].
    Okada Y; Nawata M; Tanaka Y
    Clin Calcium; 2009 Aug; 19(8):1186-90. PubMed ID: 19638703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rituximab: a new therapeutic arm in refractory rheumatoid arthritis: about one case].
    Abdelmoula LC; Testouri N; Ben Hadj Yahia C; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
    Tunis Med; 2008 Sep; 86(9):841-2. PubMed ID: 19472790
    [No Abstract]   [Full Text] [Related]  

  • 24. Rheumatoid arthritis: a rapidly evolving treatment paradigm.
    Kremer JM
    Manag Care Interface; 2007 Jul; 20(7):17, 24. PubMed ID: 17849728
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemokines and their receptors in rheumatoid arthritis: future targets?
    Koch AE
    Arthritis Rheum; 2005 Mar; 52(3):710-21. PubMed ID: 15751074
    [No Abstract]   [Full Text] [Related]  

  • 26. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comment on high HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    Dullaart RP
    Eur J Clin Invest; 2009 Jun; 39(6):533. PubMed ID: 19490063
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug management of early rheumatoid arthritis - 2008.
    Sokka T; Mäkinen H
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Attaching importance to the traditional disease modifying antirheumatic drugs].
    Yang XY
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1873-4. PubMed ID: 19039995
    [No Abstract]   [Full Text] [Related]  

  • 30. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
    Danko JR; Gilliland WR; Miller RS; Decker CF
    Scand J Infect Dis; 2009; 41(4):252-5. PubMed ID: 19266397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic targets for rheumatoid arthritis.
    Keystone EC; Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():1. PubMed ID: 19509323
    [No Abstract]   [Full Text] [Related]  

  • 32. Patient access to rheumatoid arthritis treatments.
    Jönsson B; Kobelt G; Smolen J
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S33-4. PubMed ID: 18097698
    [No Abstract]   [Full Text] [Related]  

  • 33. Speculations on why early treatment of rheumatoid arthritis is uniquely effective.
    Sharp JT
    J Rheumatol; 2008 Nov; 35(11):2090-3. PubMed ID: 19004051
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac complications may be higher with use of proteasome inhibitors in patients with rheumatoid arthritis.
    Khan S
    Med Hypotheses; 2008 Nov; 71(5):818. PubMed ID: 18650027
    [No Abstract]   [Full Text] [Related]  

  • 35. Measures of rheumatoid arthritis disease activity.
    Kirwan J
    J Rheumatol; 2009 Feb; 36(2):442-3; author reply 443-4. PubMed ID: 19208571
    [No Abstract]   [Full Text] [Related]  

  • 36. B cell depletion in early rheumatoid arthritis: a new concept in therapeutics.
    Renato GM
    Ann N Y Acad Sci; 2009 Sep; 1173():729-35. PubMed ID: 19758222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation study.
    van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
    J Rheumatol; 2009 Jul; 36(7):1380-6. PubMed ID: 19487259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al.
    Sandoo A; Toms T; Zanten JV; Carroll D; Kitas G
    Arthritis Rheum; 2009 Jun; 61(6):854-5; author reply 855-6. PubMed ID: 19479694
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-tumor necrosis factor agents are mostly used in patients with established rheumatoid arthritis compared to early disease -- a reflection of adequate clinical practice.
    Haraoui B
    J Rheumatol; 2009 Aug; 36(8):1561-2. PubMed ID: 19671804
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of autoimmune diseases after vaccination.
    Pou MA; Diaz-Torne C; Vidal S; Corchero C; Narvaez J; Nolla JM; Diaz-Lopez C
    J Clin Rheumatol; 2008 Aug; 14(4):243-4. PubMed ID: 18766128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.